Your browser doesn't support javascript.
loading
Thyrotoxicosis after iodine fortification. A 21-year Danish population-based study.
Petersen, Mads; Knudsen, Nils; Carlé, Allan; Andersen, Stig; Jørgensen, Torben; Perrild, Hans; Ovesen, Lars; Rasmussen, Lone Banke; Thuesen, Betina Heinsbaek; Pedersen, Inge Bülow.
Afiliación
  • Petersen M; Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark.
  • Knudsen N; Faculty of Medicine, Aalborg University, Aalborg, Denmark.
  • Carlé A; Department of Endocrinology, Bispebjerg Hospital, Copenhagen, Denmark.
  • Andersen S; Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark.
  • Jørgensen T; Faculty of Medicine, Aalborg University, Aalborg, Denmark.
  • Perrild H; Faculty of Medicine, Aalborg University, Aalborg, Denmark.
  • Ovesen L; Department of Geriatrics, Aalborg University Hospital, Aalborg, Denmark.
  • Rasmussen LB; Faculty of Medicine, Aalborg University, Aalborg, Denmark.
  • Thuesen BH; Centre for Clinical Research and Prevention, Glostrup University Hospital, Copenhagen, Denmark.
  • Pedersen IB; Department of Public Health, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Clin Endocrinol (Oxf) ; 89(3): 360-366, 2018 09.
Article en En | MEDLINE | ID: mdl-29851122
OBJECTIVE: Monitoring the influence of cautious iodine fortification (IF) on the incidence rate of overt thyrotoxicosis in Denmark with formerly frequent multinodular toxic goitre. DESIGN: A 21-year (1997-2017) prospective population-based study identified all new cases of overt biochemical thyrotoxicosis in two open cohorts: a Western cohort with moderate iodine deficiency (ID) and an Eastern cohort with mild ID (total n = 533 969 by 1 January 1997). A diagnostic algorithm was applied to all thyroid function tests performed within the study areas. Mandatory IF of salt was initiated in mid-2000 (13 ppm). This study is a part of DanThyr. RESULTS: The standardized incidence rate (SIR) of thyrotoxicosis at baseline (1997-1998) was 128.5/100.000/year in the cohort with moderate ID and 80.1 in the cohort with mild ID. SIR increased markedly in both cohorts during the initial years of IF (moderate/mild ID: +39/+52% in 2000-2001/2004-2005) and subsequently decreased to baseline level (mild ID) or below (moderate ID) by 2008. The decline was due to a marked decrease in the incidence rate among elderly subjects and a moderate decrease among the middle aged. The follow-up period for the mildly iodine deficient cohort was restricted to 2008. A continuous decline in SIR was observed for the remainder of the study period in the area with moderate ID (33% below baseline in 2016-2017). CONCLUSION: The rise in thyrotoxicosis incidence with cautious mandatory IF returned to baseline level after 7-8 years and levelled out at 33% below baseline in the population with previously moderate ID after 16-17 years.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tirotoxicosis / Yodo Tipo de estudio: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Clin Endocrinol (Oxf) Año: 2018 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tirotoxicosis / Yodo Tipo de estudio: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Clin Endocrinol (Oxf) Año: 2018 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Reino Unido